Patrick M. Sweeney & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Patrick M. Sweeney & Associates's AMGN Position: Q2 2026 in Review
Patrick M. Sweeney & Associates increased its Amgen (AMGN) stake by 4.5% in Q2 2026, buying an estimated $17.1K and bringing the position to 1,158 shares worth $419K. The position accounts for 0.24% of the portfolio, ranked #104.
Patrick M. Sweeney & Associates first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Patrick M. Sweeney & Associates held 1,158 shares of Amgen worth $419K as of Q2 2026.
- Patrick M. Sweeney & Associates bought 50 Amgen shares in Q2 2026, an estimated $17.1K.
- Amgen made up 0.24% of Patrick M. Sweeney & Associates's portfolio in Q2 2026, its #104 holding.
- Patrick M. Sweeney & Associates first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Patrick M. Sweeney & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.